885704-47-2

Basic information

• Product Name: 1-(5-chloro-2-nitrophenyl)-4-methylpiperidine
• Synonyms: 1-(5-chloro-2-nitrophenyl)-4-methylpiperidine
• CAS NO: 885704-47-2
• Molecular Weight: 254.716
• Mol File: 885704-47-2.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 1-(5-chloro-2-nitrophenyl)-4-methylpiperidine(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(5-chloro-2-nitrophenyl)-4-methylpiperidine(885704-47-2)
• EPA Substance Registry System: 1-(5-chloro-2-nitrophenyl)-4-methylpiperidine(885704-47-2)

Safety Data

• Hazardous Substances Data: 885704-47-2(Hazardous Substances Data)

Upstream product

• 626-58-4 4-methylpiperidin 
• 700-37-8 4-chloro-2-fluoro-nitrobenzene 
• 611-06-3 2,4-dichloronitrobenzene 

Downstream Products

• 885704-48-3 4-[3-(4-methyl-piperidin-1-yl)-4-nitro-phenyl]-morpholine 
• 885704-51-8 1-[3-(4-methyl-piperidin-1-yl)-4-nitro-phenyl]-piperazine 
• 885704-49-4 1-methyl-4-(3-(4-methylpiperidin-1-yl)-4-nitrophenyl)piperazine 
• 1022921-78-3 2-{4-[3-(4-methyl-piperidin-1-yl)-4-nitro-phenyl]-piperazin-1-yl}-ethanol 
• 1022921-74-9 C₁₇H₂₆N₄O₄S 
• 885704-52-9 tert-butyl 4-(3-(4-methylpiperidin-1-yl)-4-nitrophenyl)piperazine-1-carboxylate 
• 1160474-88-3 4-(4-methylpiperazin-1-yl)-2-(4-methylpiperidin-1-yl)aniline 
• 885704-21-2 4-cyano-N-(4-(4-methylpiperazin-1-yl)-2-(4-methylpiperidin-1-yl)phenyl)-1H-pyrrole-2-carboxamide 

Relevant articles and documents

POSITRON EMISSION TOMOGRAPHY (PET) RADIOTRACERS FOR IMAGING MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR (CSF1R) IN NEUROINFLAMMATION

Positron emission tomography (PET) radiotracers for imaging macrophage colony stimulating factor-1 receptors in a subject afflicted with or suspected of being afflicted with a neuroinflammatory or neurodegenerative disease or disorder are disclosed.

AROMATIC AMIDES AS INHIBITORS OF C-FMS KINASE

The invention relates to compounds of Formula (I), wherein A, X, R2 and W are set forth in the specification, as well as solvates, hydrates, tautomers and pharmaceutically acceptable salts thereof, that inhibit protein tyrosine kinases, especially c-fms kinase. Methods of treating autoimmune diseases; and diseases with an inflammatory component; treating metastasis from ovarian cancer, uterine cancer, breast cancer, colon cancer, stomach cancer, hairy cell leukemia and non-small lung carcinoma; and treating pain, including skeletal pain caused by tumor metastasis or osteoarthritis, or visceral, inflammatory, and neurogenic pain; as well as osteoporosis, Paget's disease, and other diseases in which bone resorption mediates morbidity including arthritis, prosthesis failure, osteolytic sarcoma, myeloma, and tumor metastasis to bone with the compounds of Formula (I), are also provided.